Drug Shortage Report for PMS-DILTIAZEM CD
Report ID | 21529 |
Drug Identification Number | 02355760 |
Brand name | PMS-DILTIAZEM CD |
Common or Proper name | DILTIAZEM |
Company Name | PHARMASCIENCE INC |
Market Status | DORMANT |
Active Ingredient(s) | DILTIAZEM HYDROCHLORIDE |
Strength(s) | 180MG |
Dosage form(s) | CAPSULE (CONTROLLED-DELIVERY) |
Route of administration | ORAL |
Packaging size | 500 |
ATC code | C08DB |
ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2017-09-04 |
Estimated end date | Unknown |
Actual end date | 2020-06-05 |
Shortage status | Resolved |
Updated date | 2020-06-09 |
Company comments | Product in discontinuation process Product to be discontinued |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-09-07 | English | Compare |
v2 | 2017-09-07 | English | Compare |
v3 | 2017-09-07 | French | Compare |
v4 | 2020-06-09 | English | Compare |
v5 | 2020-06-09 | French | Compare |
Showing 1 to 5 of 5